By Lynn Gefen ( January 31, 2025, 4:41 PM EST) -- The cannabis industry faced a slow and frustrating 2024, with little progress on the federal front. The sector has been eagerly anticipating a final rule from the U.S. Drug Enforcement Agency, proposed in 2024, that would reclassify marijuana from a Schedule I to a Schedule III drug under the U.S. Controlled Substances Act....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.